Advertisement

Topics

"PeptiDream 4587 Pharmaceuticals Healthcare Deals Alliances Profile Report" Drugs and Medication Database

06:40 EST 23rd February 2019 | BioPortfolio

Here are the most relevant "PeptiDream 4587 Pharmaceuticals Healthcare Deals Alliances Profile Report" Drugs and Medications that we have found in our database.

More Information about "PeptiDream 4587 Pharmaceuticals Healthcare Deals Alliances Profile Report" on BioPortfolio

We have published hundreds of PeptiDream 4587 Pharmaceuticals Healthcare Deals Alliances Profile Report news stories on BioPortfolio along with dozens of PeptiDream 4587 Pharmaceuticals Healthcare Deals Alliances Profile Report Clinical Trials and PubMed Articles about PeptiDream 4587 Pharmaceuticals Healthcare Deals Alliances Profile Report for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PeptiDream 4587 Pharmaceuticals Healthcare Deals Alliances Profile Report Companies in our database. You can also find out about relevant PeptiDream 4587 Pharmaceuticals Healthcare Deals Alliances Profile Report Drugs and Medications on this site too.

Showing "PeptiDream 4587 Pharmaceuticals Healthcare Deals Alliances Profile Report" Drugs and Medications, all 6

Possibly Relevant

Naglazyme [biomarin pharmaceutical inc.]

These highlights do not include all the information needed to use NAGLAZYME safely and effectively. See full prescribing information for NAGLAZYME. NAGLAZYME (galsulfase) injection for intravenous useInitial U.S. Approval: 2005

Vimizim [biomarin pharmaceutical inc.]

These highlights do not include all the information needed to use VIMIZIM safely and effectively. See full prescribing information for VIMIZIM . VIMIZIM (elosulfase alfa) injection, for intravenous use Initial U.S. Approval: 2014

Promethazine hydrochloride [northwind pharmaceuticals]

NA

Clonazepam [st marys medical park pharmacy]

Clonazepam Tablets, USP CIV Rx only,

Mometasone furoate [glenmark pharmaceuticals inc., usa]

These highlights do not include all the information needed to use MOMETASONE FUROATE CREAM safely and effectively. See full prescribing information for MOMETASONE FUROATE CREAM. MOMETASONE FUROATE Cream, 0.1% for topical use Initial U.S. Approval: 1987

Non-medicated valchlor demonstration [actelion pharmaceuticals us, inc.]

Non-medicated VALCHLOR Demonstration Gel



Advertisement
Quick Search
Advertisement
Advertisement